Propofol Adult Dosing
For induction of general anesthesia in healthy adults under 55 years (ASA I-II), administer 2-2.5 mg/kg IV, titrated as approximately 40 mg every 10 seconds until onset of anesthesia. 1
Induction of General Anesthesia
Standard Adult Patients (Age <55, ASA I-II)
- Dose: 2-2.5 mg/kg IV when unpremedicated or premedicated with oral benzodiazepines or intramuscular opioids 1
- Titration method: Administer approximately 40 mg every 10 seconds against patient response until clinical signs show onset of anesthesia 1
- Onset of action: 30-45 seconds (one arm-brain circulation time) 2
- Duration of effect: 4-8 minutes 2
Elderly, Debilitated, or ASA III-IV Patients
- Reduced dose required: 1-1.5 mg/kg IV (approximately 20 mg every 10 seconds) 1
- Critical warning: Avoid rapid bolus administration—this significantly increases risk of hypotension, apnea, airway obstruction, and oxygen desaturation 1
- These patients have reduced clearance and higher blood concentrations, necessitating dose reduction 1
Neurosurgical Patients
- Slower induction recommended: Boluses of 20 mg every 10 seconds 1
- Slower titration generally results in reduced total induction requirements (1-2 mg/kg) 1
Maintenance of General Anesthesia
- Infusion rate: 50-100 mcg/kg/min in adults to optimize recovery times 1
- Titrate downward in absence of clinical signs of light anesthesia until mild response to surgical stimulation is obtained 1
- Incremental boluses: 25-50 mg (2.5-5 mL) can be administered for stress response to surgical stimulation 1
Procedural Sedation (Non-Anesthesia Settings)
Nurse-Administered Propofol Sedation (NAPS) Protocol
- Initial bolus: 10-60 mg IV 2
- Additional boluses: 10-20 mg administered with minimum 20-30 seconds between doses 2
- Mean total doses achieved in large studies:
Emergency Department Procedural Sedation
- Initial dose: 1 mg/kg IV followed by 0.5 mg/kg supplements as needed 3, 4
- Mean dose in pediatric ED studies: 2.9-3.9 mg/kg total 4
- Allow 3-5 minutes between dose adjustments to assess clinical effects 1
Combination Propofol (with opioids/benzodiazepines)
- Lower doses required: 35-70 mg for EGD, 65-100 mg for colonoscopy when combined with fentanyl/midazolam 2
- Opioids and benzodiazepines potentiate propofol's sedative effects, requiring dose reduction 2
ICU Sedation
- Initiation: 5 mcg/kg/min (0.3 mg/kg/h) continuous infusion 1
- Titration: Increase by increments of 5-10 mcg/kg/min (0.3-0.6 mg/kg/h) with minimum 5 minutes between adjustments 1
- Maintenance range: 5-50 mcg/kg/min (0.3-3 mg/kg/h) individualized to desired sedation level 5, 1
- Maximum rate: Should not exceed 4 mg/kg/hour unless benefits outweigh risks 1
- Bolus dosing (10-20 mg) should only be used to rapidly increase sedation depth in patients unlikely to develop hypotension 1
Critical Safety Considerations
Cardiovascular Effects
- Propofol decreases cardiac output, systemic vascular resistance, and arterial pressure 2
- Negative cardiac inotropy occurs but responds rapidly to dose reduction or drug interruption 2
- Patients with compromised myocardial function, intravascular volume depletion, or abnormally low vascular tone (e.g., sepsis) are more susceptible to hypotension 1
Respiratory Effects
- Respiratory depression is common and dose-dependent 2
- Responds rapidly to dose reduction or interruption of infusion 2
- Apnea may occur, especially with rapid administration or in combination with opioids 2, 5
Drug Interactions
- Co-administration with opioids and barbiturates potentiates sedative effects 2
- Morphine premedication (0.15 mg/kg) with nitrous oxide decreases necessary propofol maintenance infusion rates 1
- When combined with midazolam and opioids, propofol doses should be reduced by approximately 30-50% 2
Contraindications and Precautions
- Avoid in patients with allergies to egg, soy, or sulfite (formulation contains egg phosphatide and soybean oil) 2
- NOT contraindicated in sulfonamide allergy 2
- Pain on injection occurs in up to 30% of patients receiving IV bolus 2
- Propofol has minimal analgesic effect—adequate analgesia must be provided separately 2
Monitoring Requirements
- Continuous pulse oximetry, blood pressure, and heart rate monitoring required 2
- Supplemental oxygen should be administered to all patients unless contraindicated 2
- Capnography should be considered, especially for deep sedation 2
Administration Technique
- Allow 3-5 minutes between dose adjustments for onset of peak drug effect 1
- Use syringe or volumetric pumps for controlled infusion rates 1
- Shake well before use; do not use if excessive creaming, large droplets, or phase separation visible 1
- Maintain vascular access throughout procedure and until patient no longer at risk for cardiorespiratory depression 6, 7